Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical… Nov 30, 2021
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent… Nov 30, 2021
Meet Dustin Robinson, The Lawyer Behind The Florida Psychedelic Investment Fund Iter Investments Nov 26, 2021
Non-Hallucinogenic Psilocybin & Mental Health: Diamond Therapeutics’ Historic Clinical Trial Begins Nov 24, 2021
Catching Up With PharmaDrug CEO Daniel Cohen On COVID-19 Treatments And Psychedelic Research Strategy Nov 23, 2021
